Alopecia universalis (AU) is a rare autoimmune condition that involves complete loss of hair on your face, scalp, and body.

Over half of patients with alopecia areata developed new-onset acne on JAK inhibitors, especially those with a personal ...

Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives,” published in the ...

Heroes and Star Wars actor Greg Grunberg has revealed that he has alopecia which he believes was triggered when he had knee ...

The Food and Drug Administration has granted Fast Track designation to bempikibart for the treatment of alopecia areata.

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases, today ...

Corinne Franklin; investor relation; Nektar Therapeutics. Howard Robin; President, Chief Executive Officer, Director; Nektar Therapeutics. Jonathan Zalevsky; Chief R ...

Q1 2025 net product revenue for ZORYVE ® (roflumilast) was $63.8 million, a 196% increase compared to Q1 of 2024, and a 2% decrease compared to Q4 of 2024, due to typical first-quarter deductible ...

Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2025.

Recognizing early signs of hair loss, such as increased hair shedding, is crucial for timely intervention. Disruptions in the ...